Download Files:
Retezorogant
SKU
HY-145590-Get quote
Category Reference compound
Tags Cancer, Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor, ROR
Products Details
Product Description
– Retezorogant is a retinoid-related orphan receptor γ (RORγ) antagonist, extracted from patent WO2016093342 A1.
Web ID
– HY-145590
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C23H33ClN2O3
References
– [1]Yokota M, et al. Preparation of dihydropyrimidine-2-one compounds as retinoid-related orphan receptor γ (RORγ) antagonists. WO2016093342 A1.
CAS Number
– 1950570-48-5
Molecular Weight
– 420.97
SMILES
– C[C@]1(C2=CC(Cl)=C(C=C2)CCC(C)(C)C)C(C(C)C)=CN(C(N1)=O)CCC(O)=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– ROR
Pathway
– Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.